Haoxi Health Technology (Haoxi Health Technology) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Haoxi Health Technology 3-Year EBITDA Growth Rate?

Haoxi Health Technology's EBITDA per Share for the six months ended in Jun. 2023 was $0.02.

During the past 12 months, Haoxi Health Technology's average EBITDA Per Share Growth Rate was 342.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of Haoxi Health Technology's 3-Year EBITDA Growth Rate

For the Advertising Agencies subindustry, Haoxi Health Technology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haoxi Health Technology's 3-Year EBITDA Growth Rate Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Haoxi Health Technology's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Haoxi Health Technology's 3-Year EBITDA Growth Rate falls into.

Haoxi Health Technology 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Haoxi Health Technology (NAS:HAO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Haoxi Health Technology 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Haoxi Health Technology's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Haoxi Health Technology (Haoxi Health Technology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » Haoxi Health Technology Ltd (NAS:HAO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Anli Road, Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang, Beijing, CHN

Website

https://www.haoximedia.com

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving leading customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

Haoxi Health Technology (Haoxi Health Technology) Headlines

From GuruFocus

Haoxi Health Technology Limited Enters into Advertising Placement Service Framework Contract

By Marketwired • 05-03-2024